Personal dialysis capacity (PDC™) test: A multicentre clinical study

Nephrology Dialysis Transplantation

Volumn 18, Issue 4, 2003, Pages 788-796

  Van Biesen, Wim ^a   Carlsson, Ola ⁿ   Bergia, Roberto ^b   Brauner, Michael ^c   Christensson, Anders ^d   Genestier, Sandrine ^e   Haag Weber, Marianne ^f   Heaf, James ^g   Joffe, Preben ^h   Johansson, Ann Cathrine ⁱ   Morel, Bertrand ^j   Prischl, Friedrich ^k   Verbeelen, Dirk ^l   Vychytil, Andreas ^m  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b OSPEDALE DEGLI INFERMI   (Italy)

^c MARTIN LUTHER KRANKENHAUS   (Germany)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e University of Rouen   (France)

^f KFH Straubing   (Germany)

^g GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^h ODENSE UNIVERSITY HOSPITAL   (Denmark)

ⁱ SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^j Chambery Hospital   (France)

^k Klinikum Wels Grieskirchen GmbH   (Austria)

^l UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^m Allgemeines Krankenhaus Stadt Wien   (Austria)

ⁿ NONE

more..

Author keywords

PDC ; Peritoneal dialysis; PET test; Renal replacement therapy

Indexed keywords

CREATININE; GLUCOSE; SERUM ALBUMIN; UREA;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANALYTIC METHOD; ARTICLE; BODY MASS; CLINICAL STUDY; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEHYDRATION; DIALYSATE; DIALYSIS MEMBRANE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY CLEARANCE; KIDNEY TUBULE ABSORPTION; MAJOR CLINICAL STUDY; MALE; MEMBRANE TRANSPORT; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS; PRIORITY JOURNAL; PROTEIN DEPLETION; ULTRAFILTRATION;

AGED; BIOLOGICAL TRANSPORT; BLOOD UREA NITROGEN; CREATININE; CROSS-SECTIONAL STUDIES; DIALYSIS SOLUTIONS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; LINEAR MODELS; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT CARE PLANNING; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONEUM; PERMEABILITY; PREDICTIVE VALUE OF TESTS; PROBABILITY; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0037385328     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg146     Document Type: Article

References (20)

1. Van Biesen W, Vanholder R, Lameire N. The role of peritoneal dialysis as the first-line renal replacement modality. Perit Dial Int 2000; 20: 375-383
2. Blake P, Burkart JM, Churchill DN et al. Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int 1996; 16: 448-456
3. Mistry CD, Gokal R. The use of glucose polymer (icodextrin) in peritoneal dialysis: an overview. Perit Dial Int 1994; 14 (Suppl 3): S158-S161
4. Wilkie ME, Plant MJ, Edwards L, Brown CB. Icodextrin 7.51% dialysate solution (glucose polymer) in patients with ultrafiltration failure: extension of CAPD technique survival. Perit Dial Int 1997; 17: 84-87
5. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001; 12: 1046-1051
6. Twardowski ZJ, Nolph KD, Khanna R. Limitations of the peritoneal equilibration test. Nephrol Dial Transplant 1995; 10: 2160-2161
7. Krediet RT, Lindholm B, Rippe B. Pathophysiology of peritoneal membrane failure. Perit Dial Int 2000; 20 (Suppl 4): S22-S42
8. Virga G, Amici G, da Rin G et al. Comparison of fast peritoneal equilibration tests with 1.36 and 3.86% dialysis solutions. Blood Purif 1994; 12: 113-120
9. Rippe B, Stelin G, Haraldsson B. Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 1991; 40: 315-325
10. Haraldsson B. Assessing the peritoneal dialysis capacities of individual patients. Kidney Int 1995; 47: 1187-1198
11. Imai H, Satoh K, Ohtani H et al. Clinical application of the Personal Dialysis Capacity (PDC) test: serial analysis of peritoneal function in CAPD patients. Kidney Int 1998; 54: 546-553
12. Haraldsson B, Broms E, Johansson AC. How to evaluate and optimize peritoneal dialysis treatment. Nephrol Dial Transplant 1998; 13 (Suppl 6): 112-116
13. Ronco C, Feriani M, Chiaramonte S et al. Peritoneal blood flow: does it matter? Perit Dial Int 1996; 16 (Suppl 1): S70-S75
14. De Vriese AS, Tilton RG, Stephan CC, Lameire NH. Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J Am Soc Nephrol 2001; 12: 1734-1741
15. Chung SH, Heimburger O, Stenvinkel P, Bergstrom J, Lindholm B. Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant 2001; 16: 2240-2245
16. Struijk DG, Krediet RT, Koomen GC et al. Functional characteristics of the peritoneal membrane in long-term continuous ambulatory peritoneal dialysis. Nephron 1991; 59: 213-220
17. Heimburger O, Waniewski J, Werynski A, Lindholm B. A quantitative description of solute and fluid transport during peritoneal dialysis. Kidney Int 1992; 41: 1320-1332
18. Paniagua R, Amato D, Vonesh E et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13: 1307-1320
19. Aslam N, Bernardini J, Fried L, Piraino B. Peritoneal dialysis clearance can replace residual renal function. Perit Dial Int 2001; 21: 263-268
20. Harty J, Boulton H, Venning M, Gokal R. Impact of increasing dialysis volume on adequacy targets: a prospective study. J Am Soc Nephrol 1997; 8: 1304-1310